These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 35990325)

  • 1. Glucagon and other proglucagon-derived peptides in the pathogenesis of obesity.
    Holst JJ
    Front Nutr; 2022; 9():964406. PubMed ID: 35990325
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Methods paper: Performance characteristics of novel assays for circulating levels of proglucagon-derived peptides and validation in a placebo controlled cross-over randomized clinical trial.
    Perakakis N; Kalra B; Angelidi AM; Kumar A; Gavrieli A; Yannakoulia M; Mantzoros CS
    Metabolism; 2022 Apr; 129():155157. PubMed ID: 35114286
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Circulating levels of five proglucagon-derived peptides in response to intravenous or oral glucose or lipids and to a mixed-meal in subjects with normal weight, overweight, and obesity.
    Perakakis N; Kokkinos A; Angelidi AM; Tsilingiris D; Gavrieli A; Yannakoulia M; Tentolouris N; Mantzoros CS
    Clin Nutr; 2022 Sep; 41(9):1969-1976. PubMed ID: 35961260
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enteroglucagon.
    Holst JJ
    Annu Rev Physiol; 1997; 59():257-71. PubMed ID: 9074764
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of the prohormone convertase PC3 in the processing of proglucagon to glucagon-like peptide 1.
    Rouillé Y; Kantengwa S; Irminger JC; Halban PA
    J Biol Chem; 1997 Dec; 272(52):32810-6. PubMed ID: 9407057
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Central pre-proglucagon derived peptides: opportunities for treatment of obesity.
    Larsen PJ; Vrang N; Tang-Christensen M
    Curr Pharm Des; 2003; 9(17):1373-82. PubMed ID: 12769729
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proglucagon processing in an islet cell line: effects of PC1 overexpression and PC2 depletion.
    Dhanvantari S; Brubaker PL
    Endocrinology; 1998 Apr; 139(4):1630-7. PubMed ID: 9528943
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gut hormones as peripheral anti obesity targets.
    Small CJ; Bloom SR
    Curr Drug Targets CNS Neurol Disord; 2004 Oct; 3(5):379-88. PubMed ID: 15544446
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of the postprandial release of peptide YY and proglucagon-derived peptides in the rat.
    Anini Y; Fu-Cheng X; Cuber JC; Kervran A; Chariot J; Roz C
    Pflugers Arch; 1999 Aug; 438(3):299-306. PubMed ID: 10398859
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Measurement of Gastrointestinal Hormones.
    Albrechtsen NJW
    Dan Med J; 2017 Nov; 64(11):. PubMed ID: 29115211
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impaired intestinal proglucagon processing in mice lacking prohormone convertase 1.
    Ugleholdt R; Zhu X; Deacon CF; Ørskov C; Steiner DF; Holst JJ
    Endocrinology; 2004 Mar; 145(3):1349-55. PubMed ID: 14630721
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting the intestinal L-cell for obesity and type 2 diabetes treatment.
    Albrechtsen NJW; Kuhre RE; Deacon CF; Holst JJ
    Expert Rev Endocrinol Metab; 2014 Jan; 9(1):61-72. PubMed ID: 30743739
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Two dipolar α-helices within hormone-encoding regions of proglucagon are sorting signals to the regulated secretory pathway.
    Guizzetti L; McGirr R; Dhanvantari S
    J Biol Chem; 2014 May; 289(21):14968-80. PubMed ID: 24727476
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proglucagon-Derived Peptides as Therapeutics.
    Lafferty RA; O'Harte FPM; Irwin N; Gault VA; Flatt PR
    Front Endocrinol (Lausanne); 2021; 12():689678. PubMed ID: 34093449
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oxyntomodulin and glucagon-like peptide-1 differentially regulate murine food intake and energy expenditure.
    Baggio LL; Huang Q; Brown TJ; Drucker DJ
    Gastroenterology; 2004 Aug; 127(2):546-58. PubMed ID: 15300587
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulation of glucagon-like peptide-1-(7-36) amide, peptide YY, and neurotensin secretion by neurotransmitters and gut hormones in the isolated vascularly perfused rat ileum.
    Dumoulin V; Dakka T; Plaisancie P; Chayvialle JA; Cuber JC
    Endocrinology; 1995 Nov; 136(11):5182-8. PubMed ID: 7588257
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of prohormone convertases in the tissue-specific processing of proglucagon.
    Dhanvantari S; Seidah NG; Brubaker PL
    Mol Endocrinol; 1996 Apr; 10(4):342-55. PubMed ID: 8721980
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Do glucagonomas always produce glucagon?
    Wewer Albrechtsen NJ; Challis BG; Damjanov I; Holst JJ
    Bosn J Basic Med Sci; 2016 Feb; 16(1):1-7. PubMed ID: 26773171
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gut hormones: a weight off your mind.
    Gardiner JV; Jayasena CN; Bloom SR
    J Neuroendocrinol; 2008 Jun; 20(6):834-41. PubMed ID: 18601707
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The physiology of glucagon-like peptide 1.
    Holst JJ
    Physiol Rev; 2007 Oct; 87(4):1409-39. PubMed ID: 17928588
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.